4//SEC Filing
Vairavan Latha 4
Accession 0002065881-25-000005
CIK 0001787306other
Filed
May 6, 8:00 PM ET
Accepted
May 7, 7:29 PM ET
Size
7.4 KB
Accession
0002065881-25-000005
Insider Transaction Report
Form 4
Vairavan Latha
SVP Chief Financial Officer
Transactions
- Award
Common Stock
2025-05-06+20,000→ 65,104 total - Award
Stock Option (right to buy)
2025-05-06+60,000→ 60,000 totalExercise: $14.32Exp: 2035-05-06→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]Represents Restricted Stock Units ("RSUs") that will vest as to 25% of the RSUs on each annual anniversary of May 1, 2025 (the "Vesting Commencement Date"), beginning on May 1, 2026, subject to the Reporting Person's continued service through the vesting date.
- [F2]The options will vest and become exercisable as to 1/48th of the shares on each monthly anniversary of May 6, 2025 (the "Vesting Commencement Date"), subject to the Reporting Person's continued service through the applicable vesting date.
Documents
Issuer
Arcutis Biotherapeutics, Inc.
CIK 0001787306
Entity typeother
Related Parties
1- filerCIK 0002065881
Filing Metadata
- Form type
- 4
- Filed
- May 6, 8:00 PM ET
- Accepted
- May 7, 7:29 PM ET
- Size
- 7.4 KB